Treatment opinion of rehabilitation in sarcopenia and cachexia for oncological patients

Česká verze

Authors: Dávid Líška ¹; Barbora Stráska ²
Authors place of work: Katedra telesnej výchovy a športu, Filozofi cká fakulta, Univerzita Mateja Bela v Banskej Bystrici, Slovenská republika ¹; Klinika pediatrickej onkológie a hematológie Slovenskej zdravotníckej univerzity v Bratislave a Detskej fakultnej nemocnice s poliklinikou Bratislava, Slovenská republika ²
Published in the journal: Klin Onkol 2020; 33(6): 421-425
Category: Přehled

Summary

Introduction: Cachexia is defined as a syndrome of multifactorial etiology characterized by severe weight loss, loss of muscle and fat mass and increase in protein catabolism. Cachexia in cancer is a predominant and debilitating syndrome. Sarcopenia is a primary disease of older age characterized by loss of muscle mass due to the aging process. Sarcopenia can be defined as a combination of low muscle strength and muscle mass. Sarcopenia often occurs in the geriatric population. Method: This is a review article, search for articles in Pubmed database, JCR and Cochrane database was made with the following keywords: “sarcopenia”, “cachexia”, “rehabilitation” and “exercise”. Result: The main therapy of rehabilitation is exercise. Exercise can reduce the inflammatory response induced by cachexia or sarcopenia. Exercise can support autophagy. Physical activity can slow down weight loss and improve skeletal muscle function. Adequate strength exercise and aerobic exercise are important benefits for patients. Strength and aerobic exercise increase muscle strength and function and represent an important treatment strategy for cachexia and sarcopenia. Conclusion: Rehabilitation treatment is an important part of treatment for patients with cachexia and sarcopenia.

Keywords:

sarcopenia – cachexia – rehabilitation – exercise

Zdroje

1. Bencsiková B, Sirotek L, Feranec R. Kazuistika pacientky s prognosticky nepříznivým metastatickým kolorektálním karcinomem léčené trifluridin/tipiracilem – příklad úspěšné multioborové spolupráce. Klin Onkol 2019; 32 (3): 232–234.

2. Baracos VE, Reiman T, Mourtzakis M et al. Body composition in patients with non−small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis. Am J Clin Nutr 2010; 91 (4): 1133S–1137S. doi: 10.3945/ajcn.2010.28608c.

3. Krejčíř R, Valík D, Vojtěšek B. Využití mitochondriálních procesů v cílené terapii nádorových onemocnění Klin Onkol 2018; 31 (Suppl 2): 14–20. doi: 10.14735/amko20182S14.

4. Trenell MI, Sue CM, Kemp GJ et al. Aerobic exercise and muscle metabolism in patients with mitochondrial myopathy. Muscle Nerve 2006; 33 (4): 524–531. doi: 10.1002/mus.20484.

5. Pahor M, Manini T, Cesari M. Sarcopenia: Clinical evaluation, biological markers and other evaluation tools. J Nutr Health Aging 2009; 13 (8): 724–728. doi: 10.1007/s12603-009-0204-9.

6. Fearon K, Strasser F, Anker SD et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011; 12 (5): 489–495. doi: 10.1016/S1470-2045 (10) 70218-7.

7. Iolascon G, Di Pietro G, Gimigliano F et al. Physical exercise and sarcopenia in older people: position paper of the Italian Society of Orthopaedics and Medicine (OrtoMed). Clin Cases Miner Bone Metab 2014; 11 (3): 215–221.

8. Büchler, T, Hornová, J. Sarkopenie u metastatického kolorektálního karcinomu. Klin Onkol 2019; 32 (6): 406–410. doi: 10.14735/amko2019406.

9. Dunne RF, Loh KP, Williams GR et al. Cachexia and sarcopenia in older adults with cancer: a comprehensive review. Cancers (Basel) 2019; 11 (12): 1861. doi: 10.3390/cancers11121861.

10. Nakashima Y, Saeki H, Nakanishi R et al. Assessment of sarcopenia as a predictor of poor outcomes after esophagectomy in elderly patients with esophageal cancer. Ann Surg 2018; 267 (6): 1100–1104. doi: 10.1097/SLA.00 00000000002252.

11. Collins J, Noble S, Chester J et al. The assessment and impact of sarcopenia in lung cancer: a systematic literature review. BMJ Open 2014; 4 (1): e003697. doi: 10.1136/bmjopen-2013-003697.

12. Fukushima H, Takemura K, Suzuki H et al. Impact of sarcopenia as a prognostic biomarker of bladder cancer. Int J Mol Sci 2018; 19 (10): 2999. doi: 10.3390/ijms19102999.

13. Loosen SH, Schulze-Hagen M, Bruners P et al. Sarcopenia is a negative prognostic factor in patients undergoing transarterial chemoembolization (TACE) for hepatic malignancies. Cancers (Basel) 2019; 11 (10): 1503. doi: 10.3390/cancers11101503.

14. Park SE, Hwang IG, Choi CH et al. Sarcopenia is poor prognostic factor in older patients with locally advanced rectal cancer who received preoperative or postoperative chemoradiotherapy. Medicine (Baltimore) 2018; 97 (48): e13363. doi: 10.1097/MD.0000000000013363.

15. Bandera EV, Fay SH, Giovannucci E et al. The use and interpretation of anthropometric measures in cancer epidemiology: A perspective from the world cancer research fund international continuous update project. Int J Cancer 2016; 139 (11): 2391–2397. doi: 10.1002/ijc.30248.

16. Čelko J, Gúth A. Sila stisku ruky. Rehabilitácia 2018; 55 (2): 68–78.

17. Zieff, GH, Wagoner W, Paterson C et al. Cardiovascular consequences of skeletal muscle impairments in breast cancer. Sports 2020; 8 (6): 80. doi: 10.3390/sports8060080.

18. Mortazavi H. Přizpůsobení nutričních intervencí molekulární patofyziologii nádorové kachexie – jak vyřešit dlouhodobý problém. Klin Onkol 2019; 32 (2): 157–158. doi: 10.14735/amko2019157.

19. Hardee JP, Counts BR, Carson JA. Understanding the Role of Exercise in Cancer Cachexia Therapy. Am J Lifestyle Med. 2017; 13 (1): 46-60. doi: 10.1177/1559827617725283.

20. Antoun S, Raynard B. Muscle protein anabolism in advanced cancer patients: response to protein and amino acids support, and to physical activity. Ann Oncol 2018; 29 (Suppl 2): ii10–ii17. doi: 10.1093/annonc/mdx809.

21. Jebavý R, Baláž J, Szarzec J. Vliv silového cvičení na hluboký stabilizační systém u extraligových hráčov futsalu. Rehabilitácia 2018; 55 (3): 173–182.

22. Peterson MD, Sen A, Gordon PM. Influence of resistance exercise on lean body mass in aging adults: A meta-analysis. Med Sci Sports Exerc 2011; 43 (2): 249–258. doi: 10.1249/MSS.0b013e3181eb6265.

23. Segal RJ, Reid RD, Courneya KS et al. Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer. J Clin Oncol 2009; 27 (3): 344–351. doi: 10.1200/JCO.2007.15.4963.

24. Winters-Stone KM, Dobek J, Bennett JA et al. The effect of resistance training on muscle strength and physical function in older, postmenopausal breast cancer survivors: a randomized controlled trial. J Cancer Surviv 2012; 6 (2): 189–199. doi: 10.1007/s11764-011-0210-x.

25. Doležel M, Odrážka K, Vaňásek J et al. Dlouhodobé klinické výsledky IGRT karcinomu prostaty. Klin Onkol 2020; 33 (1): 49-54. doi: 10.14735/amko202049.

26. Galvão DA, Taaffe DR, Spry N et al. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. J Clin Oncol 2010; 28 (2): 340–347. doi: 10.1200/JCO.2009.23.2488.

27. Liu CJ, Latham NK. Progressive resistance strength training for improving physical function in older adults. Cochrane Database Syst Rev 2009; (3): CD002759. doi: 10.1002/14651858.

28. Latham NK, Bennett DA, Stretton CM et al. Systematic review of progressive resistance strength training in older adults. J Gerontol A Biol Sci Med Sci 2004; 59 (1): 48–61. doi: 10.1093/gerona/59.1.m48.

29. Raue U, Trappe TA, Estrem ST et al. Transcriptome signature of resistance exercise adaptations: mixed muscle and fiber type specific profiles in young and old adults. J Appl Physiol (1985) 2012; 112 (10): 1625–1636. doi: 10.1152/japplphysiol.00435.2011.

30. Macháčková T, Grolich T, Fiala L. Využití sekvenování nové generace v analýze cirkulujících mikroRNA jako prediktivních biomarkerů u pacientů s lokálně pokročilým karcinomem rekta. Klin Onkol 2019; 32 (Suppl. 1): 157–159.

31. Poděbradská R, Baniarová K, Pekník O et al. Využití chůze jako pohybové intervence v praxi. Rehabilitácia 2019; 56 (3): 222–229.

32. Petriková Rosinová I, Shtin Baňarová P, Korcová J. Severská chôdza ako vhodná liečebná aktivita u pacientov s diagnózou diabetes mellitus. Rehabilitácia 2018; 55 (2): 128–136.

33. Behnoosh T, Soudeh G. Dlouhé nekódující molekuly RNA jako regulátory mitogenem aktivované proteinkinázové dráhy (MAPK) v nádorech. Klin Onkol 2018; 31 (2): 95–102. doi: 10.14735/amko201895.

34. Novosad O, Skrypets T, Pastushenko Y. Změny v signální dráze MAPK/ERK u pacientů s histiocytózou Langerhansových buněk. Klin Onkol 2018; 31 (2): 130–136. doi: 10.14735/amko2018130.

35. Rutkowska A, Jastrzebski D, Rutkowski S et al. Exercise training in patients with non-small cell lung cancer during in-hospital chemotherapy treatment: a randomized controlled trial. J Cardiopulm Rehabil Prev 2019; 39 (2): 127–133. doi: 10.1097/HCR.0000000000000410.

36. Popov DV, Lysenko EA, Bokov RO et al. Effect of aerobic training on baseline expression of signaling and respiratory proteins in human skeletal muscle. Physiol Rep 2018; 6 (17): e13868. doi: 10.14814/phy2.13868.

37. Jastrzębski D, Maksymiak M, Kostorz S et al. Pulmonary rehabilitation in advanced lung cancer patients during chemotherapy. Adv Exp Med Biol 2015; 861: 57–64. doi: 10.1007/5584_2015_134.

38. Yoo SZ, No MH, Heo JW et al. Effects of acute exercise on mitochondrial function, dynamics, and mitophagy in rat cardiac and skeletal muscles. Int Neurourol J 2019; 23 (Suppl 1): S22–31. doi: 10.5213/inj.1938038.019.

39. Urban M, Kádě O, Pavlík V et al. Telemedicine and obesity treatment. MMSL 2020; 89 (2): 74–79. doi: 10.31482/mmsl.2020.007.

40. Bird SR, Hawley JA. Update on the effects of physical activity on insulin sensitivity in humans. BMJ Open Sport Exerc Med 2017; 2 (1): e000143. doi: 10.1136/bmjsem-2016-000143.